Company: MBIO
Filing Date: 2025-02-05
Form Type: S-1/A
Source: 0001104659-25-009408
Chunk: 174

Company: MUSTANG BIO, INC.
Filing Date: 2025-02-05
Form: S-1/A
Chunk 174
---
 $     | — | (2)​ | $          |      — | ​ | $      | — | ​ | $              | — | ​ | $            |       — | ​ | $     | 501,704 |
| President, Chief Executive Officer and Interim Chief Financial Officer | ​ | 2023 | ​ | $      | 480,788 | ​ | $     | — | (2)​ | ​          | 21,050 | ​ | ​      | — | ​ | ​              | — | ​ | ​            |       — | ​ | ​     | 501,838 |
| James Murphy (4)                                                       
 Interim Chief Financial Officer                                        | ​ | 2024 | ​ | ​      |       — | ​ | ​     | — | ​    | ​          |      — | ​ | ​      | — | ​ | ​              | — | ​ | ​            | 199,485 | ​ | ​     | 199,485 |
| Eliot Lurier (5)                                                       
 Interim Chief Financial Officer                                        | ​ | 2023 | ​ | ​      |       — | ​ | ​     | — | ​    | ​          |      — | ​ | ​      | — | ​ | ​              | — | ​ | ​            | 244,283 | ​ | ​     | 244,283 |

| (1) | The amounts in the “Stock Awards” column reflect the aggregate grant date fair value of restricted stock units granted during the year computed in accordance with the provisions of FASB ASC Topic 718. The assumptions used in calculating these amounts are set forth in Note 9 to our financial statements for the year ended December 31, 2023 included elsewhere in this prospectus. |

| (2) | On October 23, 2024, the Compensation Committee elected to forgo payments for the 2023 and 2024 annual cash incentive bonuses. |

| (3) | Dr. Litchman was appointed Interim Chief Financial Officer as of November 15, 2024. |

| (4) | Effective January 19, 2024, Mr. Murphy was appointed as our Interim Chief Financial Officer, although he remained a consultant employed by Danforth Advisors, LLC (“Danforth”) and was contracted to work for us on a part time basis, as described under “Narrative to Summary Compensation Table” below. The amount shown represents fees and expenses